when were glp 1 agonists discovered A timeline of GLP- discovery and clinical development. Created in Glucagon-like peptide-1 receptor: mechanisms and
Description
Obesity is a chronic, multifactorial disease that requires a multifaceted, individualized approach to create a sustainable, adaptive plan that manages nutrition, physical activity, behavior, and selection of pharmacotherapy to optimize healthy weight loss, said Rhodes.

Primary prevention of cardiovascular disease with a Mediterranean diet supplemented with extra-virgin olive oil or nuts

FUTURE PERSPECTIVES The emergence of SGLT2 inhibitors and GLP1 receptor agonists represents a major advancement in the management of DKD

Our medical team recognizes the potential of GLP-1 medications to help patients achieve sustainable weight loss and improved metabolic health

Dominguez says

DOI: 10.4088/JCP.23m15068
